Article thumbnail

Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes

By Jason Bradfield, Roderick Tung, Noel G. Boyle and Kalyanam Shivkumar


We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator shocks

Topics: Article
Publisher: Springer US
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
  2. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
  3. (2000). Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone.
  4. (2006). Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
  5. (1999). Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.
  6. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
  7. (2000). Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the cardiac arrest study Hamburg (CASH).